NRx Pharmaceuticals Inc (NRXPW) Stock Analysis

NRx Pharmaceuticals Inc (NRXPW) is a publicly traded company in the HEALTHCARE sector. It trades at $0.00. This page summarizes the public market data, fundamentals, and frequently asked questions for NRXPW, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

About NRx Pharmaceuticals Inc

NRx Pharmaceuticals, Inc. (Ticker: NRXPW) is a clinical-stage biopharmaceutical firm headquartered in Wilmington, Delaware, dedicated to developing groundbreaking therapies for serious central nervous system disorders and lung diseases. The company is actively conducting advanced clinical trials to meet critical unmet medical needs, particularly in acute crises such as suicidal depression and respiratory ailments. With a strong commitment to improving patient outcomes and a promising pipeline...

GNG Research Analysis

GNG Research scores NRx Pharmaceuticals Inc (NRXPW) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for NRXPW.

Frequently Asked Questions

Does NRXPW pay dividends?

NRx Pharmaceuticals Inc (NRXPW) does not currently pay a regular dividend.